Brief: Duality Biotherapeutics Posts HY Adjusted Profit RMB145.9 Million
26/08/2025 11:23
Aug 26 (Reuters) - Duality Biotherapeutics Inc 9606.HK: HY ADJUSTED PROFIT RMB145.9 MILLION HY REVENUE RMB1.23 BILLION Further company coverage: 9606.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Duality Biotherapeutics
See all newsDuality Biotherapeutics rises most in near six weeks on Roche's Genentech tie-up
Brief: Duality Biotherapeutics Says Global Research And Development Collaboration And License Agreement With Genentech
Brief: Duality Biotherapeutics Obtains Acceptance From Shanghai Securities Regulatory Bureau For Counselling On Proposed RMB Share Listing
Brief: Duality Biotherapeutics Announces Share Repurchase Plan Of Up To $40 Million
Brief: Duality Biotherapeutics Approved Proposed RMB Share Issue On Sci-Tech Board